News
Four out of 10 eczema patients struggle with sleep, and they may not volunteer that information unless you ask.
Eli Lilly on Wednesday launched the easy-to-use injector pen of its blockbuster weight-loss drug Mounjaro for 14,000 rupees ...
(Reuters) -Doctors advise most patients on GLP-1 obesity drugs such as Wegovy and Zepbound to stay on them to keep the weight ...
20h
MedPage Today on MSNPharma Giant Sued Over Bribery Allegations; Medicaid $$ for the Dead; Milk and Bones
Texas Attorney General Ken Paxton said the state is suing Eli Lilly for allegedly bribing clinicians to prescribe its GLP-1 ...
More than five years after the Covid-19 pandemic first ravaged the nation, many Americans are still dealing with the social ...
StockStory.org on MSN14h
Eli Lilly (LLY) Stock Trades Up, Here Is Why
Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) jumped 3.1% in the afternoon session after reports of ...
Eli Lilly's new oral GLP-1 medication orforglipron produced an average weight loss of 12.4% (27.3 pounds) in clinical trials.
Eli Lilly has been accused of giving illegal inducements to encourage medical providers in Texas to prescribe its medicines ...
Texas Attorney General Ken Paxton has filed a lawsuit against Eli Lilly and Co. (NYSE:LLY), accusing the pharmaceutical giant ...
Texas has sued pharmaceutical giant Eli Lilly for allegedly bribing and illegally inducing medical providers to prescribe its ...
20h
TipRanks on MSNEli Lilly price target lowered to $825 from $975 at Cantor Fitzgerald
Cantor Fitzgerald analyst Carter Gould lowered the firm’s price target on Eli Lilly (LLY) to $825 from $975 and keeps an ...
14hon MSN
Why Eli Lilly Stock Popped Today
Eli Lilly is now selling Mounjaro GLP-1 weight loss drugs in India. Rival Novo Nordisk began Indian Wegovy sales in June. Lilly is underpricing its rival in the Indian weight loss market.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results